| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,032 | 0,034 | 14.11. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | THOMSON MEDICAL GROUP LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 27.10. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::RESPONSES TO SIAS QUERIES ON FY2026 ANNUAL REPORT | 2 | SGX Company Announcements | ||
| THOMSON MEDICAL Aktie jetzt für 0€ handeln | |||||
| 01.10. | THOMSON MEDICAL GROUP LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 3 | SGX Company Announcements | ||
| 01.10. | THOMSON MEDICAL GROUP LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 29.09. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::IPT - USE OF MARKET CAPITALISATION AS BASIS FOR COMPUTING MATERIALITY THRESHOLD | 2 | SGX Company Announcements | ||
| 28.08. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::TMG - FY2026 RESULTS BRIEFING | 2 | SGX Company Announcements | ||
| 27.08. | Thomson Medical cuts H2 loss by 43.9% | 3 | Singapore Business Review | ||
| 26.08. | THOMSON MEDICAL GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | 1 | SGX Company Announcements | ||
| 14.08. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT BY TMC LIFE SCIENCES BERHAD - Q4 2026 RESULTS AND FY2026 AUDITED FINANCIAL STATEMENTS | 2 | SGX Company Announcements | ||
| 01.07. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT BY TMC LIFE SCIENCES BERHAD - APPOINTMENT OF CEO OF THOMSON HOSPITALS SDN. BHD. | 1 | SGX Company Announcements | ||
| 03.06. | Billionaire Peter Lim's Thomson Medical appoints new acting CEO for Singapore business | 2 | VnExpress | ||
| 02.06. | Thomson Medical commercial chief Cassandra Loh named Singapore CEO | 2 | Singapore Business Review | ||
| 01.06. | Thomson Medical Appoints Cassandra Loh As Acting CEO For Singapore Opns, Succeeding Lee Suen Ming | 1 | RTTNews | ||
| 01.06. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::APPOINTMENT OF ACTING CEO, THOMSON MEDICAL SINGAPORE | 1 | SGX Company Announcements | ||
| 01.06. | THOMSON MEDICAL GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::CHANGE - ANNOUNCEMENT OF APPOINTMENT | 3 | SGX Company Announcements | ||
| 01.06. | THOMSON MEDICAL GROUP LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CHANGE - ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
| 20.05. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT BY TMC LIFE SCIENCES BERHAD - 3QFY2026 RESULTS ANNOUNCEMENT | 1 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 53,62 | +0,62 % | EQS-DD: Fresenius SE & Co. KGaA: Dr. Christian Pawlu, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
09.11.2026 / 09:49... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,110 | +1,39 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius Medical Care (FMC) von 38 auf 37,50 Euro gesenkt und die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,950 | +0,34 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Siemens Healthineers von 50 auf 55 Euro angehoben und die Einstufung auf "Buy" belassen. Das vierte Geschäftsquartal habe... ► Artikel lesen | |
| HEARTFLOW | 48,330 | -0,27 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| PROGYNY | 36,180 | 0,00 % | Rekorde bei Familienplanung: Progyny glänzt mit blitzsauberer Bilanz und massiven Rückkäufen | Hier an der Wall Street in New York wird oft das schnelle Geld gesucht. Doch die wahren Börsenperlen findet man häufig in lukrativen Nischen, in denen ein Unternehmen zum unverzichtbaren Marktführer... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,500 | 0,00 % | NSE - Starling Oncology, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| BRIGHTSPRING HEALTH SERVICES | 71,21 | 0,00 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| GENEDX | 52,36 | -0,02 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences:... ► Artikel lesen | |
| OTTOBOCK | 40,050 | +2,17 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): 9-Monatszahlen
Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort
12.11.2026 / 07:30 CET/CEST
Für den... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 11,500 | 0,00 % | RBC Capital reiterates Aveanna Healthcare stock rating at Outperform | ||
| NEUROPACE | 7,590 | +0,40 % | Warum die NeuroPace-Aktie heute um fast 40 % einbricht | ||
| BILLIONTOONE | 105,15 | 0,00 % | BillionToOne auf der Stifel Healthcare Conference 2026: Wachstumsdynamik gewinnt an Breite | ||
| LIFESTANCE HEALTH GROUP | 14,080 | 0,00 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| ECKERT & ZIEGLER | 15,340 | +5,79 % | EQS-News: Eckert & Ziegler SE: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): 9-Monatszahlen
Eckert & Ziegler: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt
12.11.2026 / 07:45 CET/CEST
Für... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,560 | +0,04 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |